MPTI
M-tron Industries, Inc.
MPTI trails on the overall score without a compensating advantage in the available component scores.
NVDA
NVIDIA Corporation
NVDA has the edge over MPTI overall, supported by stronger valuation and stronger modeled upside.
MPTI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
MPTI's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
MPTI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $50.58 | -25% |
| Fair | 22x | $62.00 | -8.7% |
| Current | 25x | $67.88 | — |
| Forward | 26x | $67.88 | — |
| Expensive | 29x | $80.61 | +19% |
Historical ranges are pointers, not guarantees.
MPTI's PE is in its fair range at 25x. On analysts' estimates for next year's earnings, today's price would be 26x.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over MPTI in the historical PE scenario, which offers more potential upside but is not a forecast.
MPTI Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MPTI, but weaker profitability.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
NVDA has the edge over MPTI on the outlook, with more favorable valuation expectations.
MPTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.62 | -5.1% |
| Q3 2026 | $2.76 | +16% |
| Q2 2026 | $2.67 | +4.7% |
| Q1 2026 | $2.76 | +4.2% |
| Q4 2025 | $2.63 | +0.4% |
| Q3 2025 | $2.38 | +23% |
| Q2 2025 | $2.55 | +49% |
| Q1 2025 | $2.65 | +71% |
| Q4 2024 | $2.62 | +113% |
MPTI's earnings per share have climbed steadily: $2.76 over the past year, up 16% from the year before, and higher year over year every quarter since late 2022.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over MPTI on earnings, with stronger typical year-over-year growth.
MPTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $15.7M | +11% |
| Q2 2026 | $15.1M | +14% |
| Q1 2026 | $14.7M | +15% |
| Q4 2025 | $14.2M | +11% |
| Q3 2025 | $14.2M | +7.2% |
| Q2 2025 | $13.3M | +12% |
| Q1 2025 | $12.7M | +14% |
| Q4 2024 | $12.8M | +19% |
MPTI's revenue has grown year over year every quarter since early 2022: $16M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -2.5 points |
| Q2 2026 | 11% | -2.5 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 27% | +7.2 points |
| Q3 2025 | 18% | -4.1 points |
| Q2 2025 | 14% | -4 points |
| Q1 2025 | 16% | -0.2 points |
| Q4 2024 | 20% | +21 points |
MPTI's operating margin was 16% last quarter, down 2.5 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over MPTI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over MPTI on profitability, with a higher operating margin.
MPTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.4M | -49% |
| Q2 2026 | $2.8M | +35% |
| Q1 2026 | $1.7M | +63% |
| Q4 2025 | $2.3M | +68% |
| Q3 2025 | $2.7M | +53% |
| Q2 2025 | $2M | +88% |
| Q1 2025 | $1M | -26% |
| Q4 2024 | $1.4M | -1.9% |
MPTI generated $8M in free cash flow over the past year, up 14% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over MPTI on cash flow, with more consistent year-over-year improvement.
MPTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +10.2K shares |
| 1 year | +45% | +1.3M shares |
| 3 years | +53% | +1.5M shares |
| 5 years | -19% | -1M shares |
MPTI has 4M diluted shares, up 45% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over MPTI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
MPTI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -8.2x | Net Cash |
| Q2 2026 | -8.1x | Net Cash |
| Q1 2026 | -4.3x | Net Cash |
| Q4 2025 | -1.8x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.3x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
MPTI has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MPTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.9 | Neutral |
| Stochastic | 17.0 | Oversold |
MPTI's weekly RSI is 45 (neutral) and its Stochastic is 17 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
MPTI PE vs Technology Sector
| Metric | MPTI | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 28x | 12% below |
| PE % | 57 | 41 | 16 pts above |
MPTI is trading at 25x earnings, a 12% discount to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over MPTI on valuation relative to its sector.
MPTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $68.5 | 0.9% below |
| 20 week MA | $76.5 | 11% below |
| 50 week MA | $72.1 | 5.9% below |
| 100 week MA | $60.1 | 13% above |
| 200 week MA | $44.0 | 54% above |
MPTI has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
MPTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $15.2 | $9.08 | -40% |
| 2023 | $9.08 | $35.7 | +293% |
| 2024 | $35.7 | $50.6 | +42% |
| 2025 | $50.6 | $51.2 | +1.1% |
| 2026 YTD | $51.2 | $67.9 | +33% |
MPTI has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.